Effects of intragastric balloon in patients with nonalcoholic fatty liver disease and advanced fibrosis

Intragastric Balloon Placement Induces Significant Metabolic and Histologic Improvement in Patients With Nonalcoholic Steatohepatitis

(2020) Fateh Bazerbachi et al.   Clinical Gastroenterology and Hepatology

Endoscopic bariatric and metabolic therapies for non‐alcoholic fatty liver disease: Evidence and perspectives

(2020) Federico Salomone et al.   LIVER INTERNATIONAL

Personalization of Endoscopic Bariatric and Metabolic Therapies Based on Physiology: a Prospective Feasibility Study with a Single Fluid-Filled Intragastric Balloon

(2020) Gontrand Lopez-Nava et al.   OBESITY SURGERY

ESPEN guideline on clinical nutrition in liver disease

(2019) Mathias Plauth et al.   CLINICAL NUTRITION

Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2019) Peter J. Eddowes et al.   GASTROENTEROLOGY

Association of Weight Loss Interventions With Changes in Biomarkers of Nonalcoholic Fatty Liver Disease

(2019) Dimitrios A. Koutoukidis et al.   JAMA Internal Medicine

Bariatric Surgery in Cirrhotic Patients: Is It Safe?

(2019) Hafsa Younus et al.   OBESITY SURGERY

Fluid-Filled Versus Gas-Filled Intragastric Balloons as Obesity Interventions: a Network Meta-analysis of Randomized Trials

(2018) Fateh Bazerbachi et al.   OBESITY SURGERY

Brazilian Intragastric Balloon Consensus Statement (BIBC): practical guidelines based on experience of over 40,000 cases

(2018) Manoel Galvao Neto et al.   Surgery for Obesity and Related Diseases

Incidence of nausea and vomiting after intragastric balloon placement in bariatric patients – A systematic review and meta-analysis

(2018) Judy Trang et al.   International Journal of Surgery

Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis

(2018) Zobair Younossi et al.   HEPATOLOGY

Relationship Between Three Commonly Used Non-invasive Fibrosis Biomarkers and Improvement in Fibrosis Stage in Patients With NASH

(2018) Naga Chalasani et al.   LIVER INTERNATIONAL

Endoscopic Bariatric and Metabolic Therapies: New and Emerging Technologies

(2017) Shelby Sullivan et al.   GASTROENTEROLOGY

Intragastric balloon as an adjunct to lifestyle intervention: a randomized controlled trial

(2016) A Courcoulas et al.   INTERNATIONAL JOURNAL OF OBESITY

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis

(2015) Eduardo Vilar-Gomez et al.   GASTROENTEROLOGY

Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States

(2015) Robert J. Wong et al.   GASTROENTEROLOGY

Total Body Weight Loss of ≥10 % Is Associated with Improved Hepatic Fibrosis in Patients with Nonalcoholic Steatohepatitis

(2014) Lisa M. Glass et al.   DIGESTIVE DISEASES AND SCIENCES

Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study

(2012) Yin-Mei Lee et al.   GASTROINTESTINAL ENDOSCOPY

Safety and Effectiveness of the Intragastric Balloon for Obesity. A Meta-Analysis

(2008) Iñaki Imaz et al.   OBESITY SURGERY